Levels of endothelin-1 in embryos from control and neonatal streptozotocin-induced diabetic rats, and their relationship with nitric oxide generation

Reproduction, Fertility and Development

Volumn 14, Issue 1-2, 2002, Pages 23-28

  Sinner, Debora ^a   Jawerbaum, Alicia ^a   Pustovrh, Carolina ^a   White, Verónica ^a   Capobianco, Evangelina ^a   Gonzalez, Elida ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Diabetes in pregnancy; Diabetic embryo malformations; Prostaglandin E2

Indexed keywords

BOSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE; PROSTAGLANDIN E2; PROSTANOID; SPERMINE DERIVATIVE; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO GROWTH; EMBRYOPATHY; FETUS DEVELOPMENT; GROWTH REGULATION; NEWBORN; NONHUMAN; PROSTAGLANDIN SYNTHESIS; RAT; STREPTOZOCIN DIABETES;

ABNORMALITIES, MULTIPLE; ANIMALS; ANIMALS, NEWBORN; CASE-CONTROL STUDIES; DIABETES MELLITUS, EXPERIMENTAL; DINOPROSTONE; EMBRYO; ENDOTHELIN-1; FEMALE; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRITES; OMEGA-N-METHYLARGININE; PREGNANCY; PREGNANCY IN DIABETICS; PROTEINS; RATS; RATS, WISTAR; SPERMINE; STREPTOZOCIN;

ANIMALIA;

EID: 0036244533     PISSN: 10313613     EISSN: None     Source Type: Journal    
DOI: 10.1071/RD01053     Document Type: Article

References (45)

1. Cloning and expression of a cDNA encoding an endothelin receptor
2. Endothelin messenger RNA and receptors are differentially expressed in cultured human breast epithelial and stromal cells
3. Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
5. Mouse preproendothelin-1 gene cDNA cloning, sequence analysis and determination of sites of expression during embryonic development
6. Diabetes-induced myocardial structural changes: Role of endothelin-1 and its receptors
7. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist
8. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen
9. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages
10. Diabetic embryopathy. Studies with animal and in vitro models
11. Neutrophil-endothelial cell interactions in the lung
12. 15N-nitrate in biological fluids
13. Evolution of streptozotocin-pancreatic damage in the rat: Effect of endothelins on the nitridergic and prostanoid pathway
14. Prevention of diabetes associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos
15. Elevated endothelin levels are associated with increased placental resistance
16. Endothelin emerging role in diabetic vascular complications
17. Increased prostaglandin E generation and enhanced nitric oxide synthase activity in the non-insulin-dependent diabetic embryo during organogenesis
18. 2 generation in diabetic embryo: Effect of nitric oxide and superoxide dismutase
19. Expression of endothelin-1 in pancreatic tissue of patients with chronic pancreatitis
20. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells
21. Elevated blood pressure and cranofacial abnormalities in mice deficient in endothelin-1
22. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1
23. G-monomethil-L-arginine
24. Physiologic and cellular insulin action in a glucose-intolerant model of type 2 (non-insulin-dependent) diabetes in rats
25. Epidemiological analysis of outcomes of pregnancy in diabetic mothers: Identification of the most characteristics and most frequent congenital anomalies
26. Elevated maternal hemoglobin a in early pregnancy and major congenital anomalies in infants of diabetic mothers
27. Malformations in infants of diabetic mothers
28. Actions of endothelin-1 on prostaglandin production by gestational tissues
29. Endothelin production by amnion and its regulation by cytokines
30. Nitric oxide: Physiology, pathophysiology and pharmacology
31. Elevated urine excretion of endothelins in streptozotocin-diabetic rats
32. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas
33. Endothelin-1-induced placental and fetal growth restriction in the rat
34. Diabetes mellitus affects prostaglandin E2 levels in mouse embryos during neurulation
35. Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes
36. Limb reduction defects after prenatal inhibition of nitric oxide syntheses in rats
37. Role of thromboxane A2/prostaglandin H2 receptor in the vasoconstrictor response of rat aorta to endothelin
38. Circulating plasma endothelin-1, plasma lipids and complications in type I diabetes mellitus
39. Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipemia
40. Malformations in offspring of diabetic rats: Morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment
41. Endothelin-1 induced mitogenic responses of Chinese hamster ovary cells expressing human endothelin A: The role of wortmannin-sensitive signaling pathway
42. Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits
43. The role of prostanoids in the development of diabetic embryopathy
44. A novel vasoconstrictor peptide produced by vascular endothelial cells
45. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development